Physician profile
Daniel H Hu
NPI 1811990195
$1,488.94
in general payments reported to CMS, 2019-2025
25 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2020: $44.71 · 2021: $439 · 2022: $422 · 2023: $189 · 2024: $73.83 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $397.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $205.18 | 2019-2022 | |
| Abbvie INC. | $156.60 | 2019-2024 | |
| Hologic Sales and Service, LLC | $144.54 | 2022-2025 | Novasure, Aptima, Myosure Tissue Removal Device |
| Exeltis, USA INC. | $141.36 | 2020-2025 | Slynd |
| Organon LLC | $128.05 | 2021-2024 | |
| Mayne Pharma Commercial LLC | $86.60 | 2022-2023 | |
| Myovant Sciences INC. | $79.34 | 2022 | |
| Coopersurgical, INC. | $67.62 | 2021-2023 | Paragard T 380a |
| Astellas Pharma US INC | $63.79 | 2025 | Veozah |
| Merck Sharp & Dohme LLC | $58.88 | 2019-2021 | |
| Baxter Healthcare | $44.99 | 2021 | |
| Mylan Pharmaceuticals INC. | $43.52 | 2020-2021 | |
| Intuitive Surgical, INC. | $40.00 | 2019 | |
| Therapeuticsmd, INC. | $33.06 | 2019 | |
| Davol INC. | $28.30 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $25.72 | 2021-2024 | V-Loc 180 |
| Biogen, INC. | $21.81 | 2025 | Zurzuvae |
| Optumhealth Care Solutions, LLC | $19.48 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Pfizer INC. | $19.03 | 2021 | |
| Evofem Biosciences, INC. | $15.39 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.19 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $15.05 | 2023 | Seglentis |
| Abbott Laboratories | $12.42 | 2019 | |
| Ethicon US, LLC | $12.05 | 2019 | |
| Lupin INC. | $10.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Hu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.